See more : Swift Networks Group Limited (SW1.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Hudson Technologies, Inc. (HDSN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hudson Technologies, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Hakers Enterprise Co., Ltd. (4432.TWO) Income Statement Analysis – Financial Results
- Enterprise Bancorp, Inc. (EBTC) Income Statement Analysis – Financial Results
- Kaixin Auto Holdings (KXINW) Income Statement Analysis – Financial Results
- The Kroger Co. (KR) Income Statement Analysis – Financial Results
- Lease IT Public Company Limited (LIT.BK) Income Statement Analysis – Financial Results
Hudson Technologies, Inc. (HDSN)
About Hudson Technologies, Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service for facility's refrigeration systems and other energy systems applications; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was incorporated in 1991 and is headquartered in Woodcliff Lake, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 289.03M | 325.23M | 192.75M | 147.61M | 162.06M | 166.53M | 140.38M | 105.48M | 79.72M | 55.81M | 58.63M | 56.45M | 44.32M | 37.27M | 24.17M | 33.17M | 26.89M | 23.45M | 19.22M | 14.61M | 17.96M | 19.96M | 20.77M | 15.46M | 17.90M | 23.30M | 23.00M | 19.60M | 22.00M | 1.30M |
Cost of Revenue | 177.52M | 162.33M | 121.08M | 112.20M | 144.89M | 173.89M | 102.40M | 74.40M | 61.23M | 49.36M | 59.36M | 33.91M | 35.64M | 29.24M | 20.36M | 21.86M | 20.04M | 16.61M | 11.72M | 9.01M | 13.05M | 14.51M | 14.97M | 10.40M | 14.10M | 17.60M | 18.80M | 14.10M | 12.60M | 300.00K |
Gross Profit | 111.51M | 162.89M | 71.66M | 35.41M | 17.17M | -7.37M | 37.98M | 31.09M | 18.49M | 6.45M | -730.00K | 22.54M | 8.69M | 8.03M | 3.81M | 11.31M | 6.85M | 6.84M | 7.50M | 5.61M | 4.91M | 5.46M | 5.80M | 5.06M | 3.80M | 5.70M | 4.20M | 5.50M | 9.40M | 1.00M |
Gross Profit Ratio | 38.58% | 50.09% | 37.18% | 23.99% | 10.59% | -4.42% | 27.06% | 29.47% | 23.19% | 11.55% | -1.25% | 39.93% | 19.60% | 21.55% | 15.77% | 34.10% | 25.48% | 29.16% | 39.03% | 38.36% | 27.35% | 27.34% | 27.91% | 32.73% | 21.23% | 24.46% | 18.26% | 28.06% | 42.73% | 76.92% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.83M | 6.13M | 4.71M | 4.72M | 4.91M | 4.00M | 3.69M | 3.23M | 3.78M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.31M | 4.18M | 2.72M | 3.03M | 2.75M | 2.15M | 2.19M | 1.80M | 2.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 30.54M | 28.59M | 26.57M | 26.64M | 30.02M | 32.27M | 21.75M | 12.14M | 10.31M | 7.43M | 7.76M | 7.66M | 6.16M | 5.88M | 5.03M | 5.89M | 9.21M | 4.66M | 4.30M | 4.47M | 5.21M | 6.77M | 6.80M | 6.18M | 6.00M | 6.90M | 7.60M | 5.90M | 5.70M | 700.00K |
Other Expenses | 2.79M | 2.79M | 2.79M | 2.86M | 2.93M | 2.97M | 1.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 619.00K | 733.00K | 1.23M | 1.14M | 1.22M | 1.29M | 1.30M | 1.20M | 1.50M | 1.10M | 600.00K | 100.00K |
Operating Expenses | 33.34M | 31.38M | 29.36M | 29.51M | 32.95M | 35.24M | 22.85M | 12.14M | 10.31M | 7.43M | 7.76M | 7.66M | 6.16M | 5.88M | 5.03M | 5.89M | 9.21M | 4.66M | 4.92M | 5.20M | 6.45M | 7.91M | 8.02M | 7.47M | 7.30M | 8.10M | 9.10M | 7.00M | 6.30M | 800.00K |
Cost & Expenses | 210.85M | 193.72M | 150.44M | 141.70M | 177.84M | 209.13M | 125.25M | 86.53M | 71.54M | 56.80M | 67.12M | 41.57M | 41.79M | 35.12M | 25.38M | 27.75M | 29.25M | 21.27M | 16.64M | 14.21M | 19.50M | 22.42M | 22.99M | 17.86M | 21.40M | 25.70M | 27.90M | 21.10M | 18.90M | 1.10M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 8.35M | 14.33M | 11.38M | 12.33M | 18.91M | 14.76M | 3.16M | 1.12M | 776.00K | 641.00K | 933.00K | 693.00K | 881.00K | 1.10M | 1.40M | 1.17M | 768.00K | 345.00K | 303.00K | 341.00K | 934.00K | 347.00K | 423.00K | 501.00K | 0.00 | 400.00K | 0.00 | 500.00K | 300.00K | 100.00K |
Depreciation & Amortization | 5.78M | 5.98M | 6.18M | 6.10M | 2.93M | 2.97M | 1.11M | 2.23M | 2.07M | 979.00K | 808.00K | 556.00K | 497.00K | 540.00K | 524.00K | 547.00K | 561.00K | 565.00K | 619.00K | 733.00K | 1.20M | 1.14M | 1.22M | 1.29M | 1.30M | 1.20M | 1.50M | 1.10M | 600.00K | 100.00K |
EBITDA | 83.95M | 137.49M | 50.96M | 13.03M | 743.00K | -35.48M | 25.64M | 21.17M | 10.25M | -6.00K | -7.68M | 15.45M | 3.05M | 2.71M | -689.00K | 5.97M | -1.77M | 2.71M | 3.20M | 932.00K | -337.00K | -1.31M | -1.00M | -1.12M | -2.20M | -1.20M | -3.50M | -400.00K | 3.70M | 300.00K |
EBITDA Ratio | 29.05% | 42.27% | 26.44% | 8.83% | -2.12% | -23.80% | 11.59% | 17.43% | 10.64% | -1.76% | -14.47% | 26.36% | 6.83% | 7.22% | -2.86% | 17.98% | -6.75% | 11.55% | 16.64% | 6.38% | -0.12% | -7.96% | -5.99% | -10.54% | -12.85% | -5.58% | 22.61% | 3.57% | 16.36% | 23.08% |
Operating Income | 78.17M | 131.51M | 42.31M | 5.90M | -15.78M | -42.61M | 15.13M | 18.95M | 8.18M | -985.00K | -8.49M | 14.88M | 2.53M | 2.15M | -1.21M | 5.42M | -2.35M | 2.18M | 2.59M | 402.00K | -1.53M | -2.45M | -2.22M | -2.41M | -3.50M | -2.40M | -4.90M | -1.50M | 3.10M | 200.00K |
Operating Income Ratio | 27.05% | 40.44% | 21.95% | 4.00% | -9.74% | -25.59% | 10.78% | 17.96% | 10.26% | -1.76% | -14.47% | 26.36% | 5.70% | 5.77% | -5.02% | 16.33% | -8.75% | 9.30% | 13.46% | 2.75% | -8.53% | -12.29% | -10.69% | -15.57% | -19.55% | -10.30% | -21.30% | -7.65% | 14.09% | 15.38% |
Total Other Income/Expenses | -8.35M | -14.33M | -8.91M | -11.30M | -9.50M | -14.76M | -3.13M | -1.68M | -474.00K | -641.00K | -933.00K | -684.00K | -860.00K | -1.09M | -1.40M | -1.17M | -746.00K | -307.00K | -294.00K | -138.00K | -899.00K | -69.00K | -179.00K | 512.00K | 100.00K | 100.00K | -9.30M | -1.70M | -200.00K | -200.00K |
Income Before Tax | 69.82M | 117.18M | 33.40M | -5.39M | -25.28M | -57.36M | 12.00M | 17.27M | 7.71M | -1.63M | -9.42M | 14.20M | 1.67M | 1.06M | -2.61M | 4.25M | -3.10M | 1.88M | 2.29M | 264.00K | -2.43M | -2.52M | -2.40M | -2.40M | -4.00M | -2.70M | -14.30M | -3.20M | 2.90M | 0.00 |
Income Before Tax Ratio | 24.16% | 36.03% | 17.33% | -3.65% | -15.60% | -34.45% | 8.55% | 16.37% | 9.67% | -2.91% | -16.06% | 25.15% | 3.76% | 2.85% | -10.82% | 12.81% | -11.53% | 8.00% | 11.93% | 1.81% | -13.54% | -12.63% | -11.55% | -15.50% | -22.35% | -11.59% | -62.17% | -16.33% | 13.18% | 0.00% |
Income Tax Expense | 17.57M | 13.38M | 1.14M | -185.00K | 656.00K | -1.70M | 847.00K | 6.63M | 2.94M | -906.00K | -3.58M | 1.40M | 634.00K | 363.00K | -119.00K | -2.42M | -1.14M | -233.00K | 24.00K | 138.00K | 899.00K | 69.00K | 179.00K | 2.40M | 4.00M | 2.70M | 2.00M | -1.10M | 1.10M | 0.00 |
Net Income | 52.25M | 103.80M | 32.26M | -5.21M | -25.94M | -55.66M | 11.16M | 10.64M | 4.76M | -720.00K | -5.84M | 12.80M | 1.03M | 701.00K | -2.50M | 6.67M | -1.96M | 2.11M | 2.27M | 264.00K | -2.43M | -2.52M | -2.40M | -2.40M | -4.00M | -2.70M | -16.30M | -2.10M | 1.80M | 0.00 |
Net Income Ratio | 18.08% | 31.92% | 16.74% | -3.53% | -16.01% | -33.42% | 7.95% | 10.08% | 5.97% | -1.29% | -9.96% | 22.68% | 2.33% | 1.88% | -10.32% | 20.11% | -7.29% | 8.99% | 11.81% | 1.81% | -13.54% | -12.63% | -11.55% | -15.50% | -22.35% | -11.59% | -70.87% | -10.71% | 8.18% | 0.00% |
EPS | 1.15 | 2.31 | 0.74 | -0.12 | -0.61 | -1.31 | 0.27 | 0.31 | 0.15 | -0.02 | -0.24 | 0.54 | 0.04 | 0.03 | -0.12 | 0.35 | -0.09 | 0.08 | 0.09 | 0.00 | -0.46 | -0.49 | -0.47 | -0.47 | -0.79 | -0.52 | -3.26 | -0.47 | 0.46 | 0.02 |
EPS Diluted | 1.10 | 2.20 | 0.69 | -0.12 | -0.61 | -1.31 | 0.26 | 0.30 | 0.14 | -0.02 | -0.24 | 0.49 | 0.04 | 0.03 | -0.12 | 0.33 | -0.09 | 0.08 | 0.09 | 0.00 | -0.46 | -0.49 | -0.47 | -0.47 | -0.79 | -0.52 | -3.26 | -0.47 | 0.43 | 0.02 |
Weighted Avg Shares Out | 45.39M | 44.99M | 43.77M | 42.71M | 42.61M | 42.48M | 41.76M | 34.10M | 32.55M | 29.12M | 24.83M | 23.91M | 23.78M | 22.37M | 20.05M | 19.27M | 22.21M | 25.90M | 25.59M | 21.39M | 5.27M | 5.16M | 5.10M | 5.09M | 5.09M | 5.19M | 5.00M | 4.47M | 3.46M | 2.54M |
Weighted Avg Shares Out (Dil) | 47.34M | 47.11M | 46.64M | 42.71M | 42.61M | 42.48M | 42.77M | 35.42M | 33.94M | 29.12M | 24.83M | 26.35M | 24.80M | 23.72M | 20.05M | 20.31M | 22.21M | 26.26M | 25.73M | 21.42M | 5.27M | 5.16M | 5.10M | 5.09M | 5.09M | 5.19M | 5.00M | 4.47M | 3.46M | 2.54M |
Hudson Technologies (HDSN) Beats Q3 Earnings Estimates
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care
Hudson Global to Report Third Quarter 2024 Financial Results on November 12th
Hudson Technologies Board of Directors Approves Increase to Company's Share Repurchase Program
Old Navy Unveils 'Love is in the House' in Holiday Campaign with Jennifer Hudson
Hudson Technologies to Host Conference Call to Discuss Third Quarter 2024 Results
Hudson Pacific Properties Announces Date for Third Quarter Earnings Release and Conference Call
Hudson Technologies Comments on the EPA's Issuance of Final Refrigerant Management Rule
Hudson RPO Celebrates 16 Consecutive Years on HRO Today's Baker's Dozen List of Top Global RPO Providers
Jennifer Hudson and the Iconic Dawn Ducklings Flock Together to Eliminate Grease in the Kitchen and on Delicate Feathers
Source: https://incomestatements.info
Category: Stock Reports